Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila E Taube

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|November 13, 2009
Biomarkers in oncology: trials and tribulationsSheila E Taube
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 25, 2012
Challenges in drug and biomarker co-developmentSheila E Taube, Tracy Lively
Personalized Medicine|May 24, 2018
Program for the Assessment of Clinical Cancer Tests (PACCT): assisting the development of tailored cancer therapySheila E Taube, Jeffrey S Abrams
Disease Markers|August 24, 2004
Prognostic and predictive markers in cancerBarbara A Conley, Sheila E Taube
Seminars in Oncology|June 14, 2002
Issues and barriers to development of clinically useful tumor markers: a development pathway proposalM Elizabeth H Hammond, Sheila E Taube
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|December 13, 2005
Cancer diagnostics: decision criteria for marker utilization in the clinicSheila E Taube, James W Jacobson, Tracy G Lively
Plos Medicine|June 8, 2012
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaborationDouglas G Altman, Lisa M McShane, Willi Sauerbrei, et al.
BMC Medicine|May 31, 2012
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaborationDouglas G Altman, Lisa M McShane, Willi Sauerbrei, et al.
Journal of the National Cancer Institute|June 7, 2018
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and ElaborationWilli Sauerbrei, Sheila E Taube, Lisa M McShane, et al.
Journal of the National Cancer Institute|August 18, 2005
Reporting recommendations for tumor marker prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|November 13, 2009
Biomarkers in oncology: trials and tribulationsSheila E Taube
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 25, 2012
Challenges in drug and biomarker co-developmentSheila E Taube, Tracy Lively
Personalized Medicine|May 24, 2018
Program for the Assessment of Clinical Cancer Tests (PACCT): assisting the development of tailored cancer therapySheila E Taube, Jeffrey S Abrams
Disease Markers|August 24, 2004
Prognostic and predictive markers in cancerBarbara A Conley, Sheila E Taube
Seminars in Oncology|June 14, 2002
Issues and barriers to development of clinically useful tumor markers: a development pathway proposalM Elizabeth H Hammond, Sheila E Taube
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|December 13, 2005
Cancer diagnostics: decision criteria for marker utilization in the clinicSheila E Taube, James W Jacobson, Tracy G Lively
Plos Medicine|June 8, 2012
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaborationDouglas G Altman, Lisa M McShane, Willi Sauerbrei, et al.
BMC Medicine|May 31, 2012
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaborationDouglas G Altman, Lisa M McShane, Willi Sauerbrei, et al.
Journal of the National Cancer Institute|June 7, 2018
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and ElaborationWilli Sauerbrei, Sheila E Taube, Lisa M McShane, et al.
Journal of the National Cancer Institute|August 18, 2005
Reporting recommendations for tumor marker prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
Pageof 2